Article info

Download PDFPDF

Extended report
The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region

Authors

  1. Correspondence to Professor Xavier Mariette; xavier.mariette{at}bct.aphp.fr
View Full Text

Citation

Mariette X, Vencovsky J, Lortholary O, et al
The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region

Publication history

  • Received December 29, 2014
  • Revision received March 1, 2015
  • Accepted March 27, 2015
  • First published April 28, 2015.
Online issue publication 
April 28, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.